Workflow
Chromocell to Participate in the Virtual Investor Lunch Break Series
CHROChromocell Therapeutics(CHRO) GlobeNewswire News Room·2024-07-15 13:00

As part of the event, Frank Knuettel II, Chief Executive Officer and Chief Financial Officer of Chromocell, will provide a corporate overview and business outlook. In addition to the prepared remarks, interested parties will have the opportunity to submit questions live during the event. Mr. Knuettel will answer as many questions as possible in the time allowed. About Chromocell Therapeutics LR Advisors LLC. Jason Assad 678-570-6791 Jason@Chromocell.com FREEHOLD, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Chro ...